Bioinformatic studies show that RCC2 is associated with Exportin-1 (XPO1), which is a crucial factor in a complex mechanism of bortezomib resistance in multiple myeloma (Figure 3) (Chanukuppa et al., 2019). This evidence concerns the gene XPO1 and plasma cell myeloma.